Previously reported MRD negative CR in 2 of 3 relapsed/refractory AML patients enrolled in first dose level and schedule of Phase 1 clinical ...

Pieridae Energy Limited ( OTCPK:PTOAF) Q4 2024 Earnings Conference Call March 20, 2025 10:30 AM ET Dallas McConnell - Vice President, Corporate Finance Darcy Reding - President and Chief Executive ...

The number of housing projects granted planning permission in England in 2024 hit a record low, according to new government ...

Operator Good morning, ladies and gentlemen, and thank you for standing by for Baozun's fourth-quarter 2024 earnings conference call. At this time, all participants are in a listen-only mode. After ...

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025Upon FDA approval, ...

Boston College men’s basketball forward Elijah Strong is planning to enter the transfer portal, according to a report from ...

Reported positive data updates from its ongoing Phase 2a trial of lead program IMM-1-104, including encouraging responses in combination with chemotherapy in first-line pancreatic cancer - - Announced ...

Q4 2024 Results Conference Call March 19, 2025 6:00 PM ETCompany ParticipantsPaul Antony - Executive ChairmanSam Cochrane ...

A new plan would add hundreds of for-sale and rental homes to Chester County, but local government officials are skeptical.

There wasn’t a dry eye in the Devereux Room at the Hotel Colorado on Saturday night when Sumner Schachter was named the 2024 ...

New Drug Application (NDA) for LNZ100 for treatment of presbyopia on track for PDUFA target action date of August 8, 2025 Upon FDA approval, commercial launch activities to commence immediately with ...

FDA granted priority review to Company's BLA for PRGN-2012 for the treatment of adults with recurrent respiratory papillomatosis and set PDUFA target action date ...